The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.

Explore how reducing cost helps drive commercialization and reimbursement while economic modeling and process optimization enhance CGT potential.

“Gilead has confirmed to us its intention to support manufacturing in South Africa,” Unitaid director of program Robert Matiru told BioProcess Insider. “This initiative will help identify capable ...

Last month, large pharmaceutical conglomerate Merck filed a worker adjustment and retraining notification (WARN) notice with ...

A research team from London examined the relationship between adenovirus-associated virus (AAV)-based vectors and liver ...

Eppendorf experts discuss regulatory challenges, single-use technologies, and digitalization strategies for scaling from R&D to commercial manufacturing.

Explore the latest news and expert commentary by Lakshmana Kumar Arlagadda, brought to you by the Contributor of BioProcess ...

Explore the latest news and expert commentary by G. Krishna Prasad, brought to you by the Contributor of BioProcess ...

In a panel discussion at the BioProcess International (BPI) West conference in San Diego, California, this week, industry experts discussed how rapid advancements in AI technology are leading to ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Facility commissioning and qualification (C&Q) success begins with project setup meetings that align stakeholders, project metrics, and mitigate risks.